17 projects with direct impact on people in LMICs, balanced across therapy, prevention, and diagnostics = the largest global health portfolio against AMR

😂😂

We found that "Collaborations focus so far more on material transfer than active knowledge sharing" in a new piece on #COVID19 #Vaccine R&D partnerships. Check out the in-press piece co-authored with Nicholson Price (@[email protected]) and Timo Minssen sciencedirect.com/science/articl… CeBIL #pharmpol

Sure, but let's not ignore the massive stockpiles the US and European countries have amassed and the additional steps they can take. More to come...

Denmark rolled back #COVID19 restrictions because it is no longer considered a public threat, but let's remember that it is not because the virus is not present anymore #pharmpol

Fascinating! This is definitely a new update to pharmacology classes taught! #pharmacology #gutbacteria #pharmacy #pharmacyeducation

The day came, the first non-insulin #biosimilar approved as #interchangeable by the U.S. FDA! fda.gov/news-events/pr… #biologics

I did not know this and I am EXTREMELY happy that now I do!

Getting inspired by #EMA's Violeta Stoyanova-Beninska on extrapolation between age groups for #orphandrugs. These drugs are in focus at today's conference at Copenhagen Centre for Regulatory Science. Presenters include CeBIL's jakob wested! Københavns Uni #regulatoryscience

Who could have seen a new variant arising against a background of profound global vaccine inequity? Who, I ask you‽ (Everyone! This was entirely predictable! Basically guaranteed to happen!)

What do EU national regulators and industry think of #interchangeability of #biosimilars? Check out our new study in PLOS One with S. Kälvemark Sporrong, Timo Minssen, H Hoogland, Marieke De Bruin, @WeertMarco, AB Almarsdóttir. journals.plos.org/plosone/articl… UCPH Healthscience CeBIL

Are you trained in the natural sciences or do you just want to improve your conduct of #qualitative research? See this piece on reflexivity, saturation, quality criteria and use of check-lists! Co-authors include Lotte Stig Nørgaard WHO Center: Patients & medicines @MathiasMlbk Lou Cantarero. UCPH Healthscience

How do patients experience receiving biologics treatments? And how can biosimilars be seen, even in Denmark with a general high biosimilar uptake? See more about this in our new study led by Meera Varma. onlinelibrary.wiley.com/doi/10.1111/bc… #biologics #biosimilar #patientexperience

#AntibioticResistance kills 1.27m people annually, more than HIV & malaria combined. How can #AMRSocSci #SocSciAMR help to tackle this grim threat? Join us on Oct. 5th to 6th in Copenhagen to discuss it. No time to waste! Check the program & register here: jura.ku.dk/cebil/calendar…

Happy to contribute with Timo Minssen on regulatory responses to medical #MachineLearning at Int’l Telecommunication Union/World Health Organization (WHO) Workshop on #AI in #Health. Research on this includes CLASSICA on AI-based clinical decision support to cancer surgeons CeBIL University of Copenhagen Research #medicaldevices

⚙️ CLASSICA was recently featured at the Int’l Telecommunication Union-World Health Organization (WHO) workshop on AI for Health! 📢 Louise C. Druedahl and Timo Minssen discussed regulatory responses to medical #MachineLearning and talked about how CLASSICA AI will support cancer surgeons Read more 👉classicaproject.eu/2022/09/cebil-…